The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.
<h4>Background</h4>The prediction of breast cancer intrinsic subtypes has been introduced as a valuable strategy to determine patient diagnosis and prognosis, and therapy response. The PAM50 method, based on the expression levels of 50 genes, uses a single sample predictor model to assig...
Main Authors: | Heloisa Helena Milioli, Renato Vimieiro, Carlos Riveros, Inna Tishchenko, Regina Berretta, Pablo Moscato |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0129711 |
Similar Items
-
Basal-like breast cancer: molecular profiles, clinical features and survival outcomes
by: Heloisa H. Milioli, et al.
Published: (2017-03-01) -
Cancer biomarker discovery: the entropic hallmark.
by: Regina Berretta, et al.
Published: (2010-01-01) -
Extensive Transcriptomic and Genomic Analysis Provides New Insights about Luminal Breast Cancers.
by: Inna Tishchenko, et al.
Published: (2016-01-01) -
MetabR: an R script for linear model analysis of quantitative metabolomic data
by: Ernest Ben, et al.
Published: (2012-10-01) -
CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
by: Kelly E. Craven, et al.
Published: (2021-02-01)